The cost of immunotherapy for prostate cancer in Ukraine typically ranges from $9,000 to $17,000. Prices can vary depending on the specific immunotherapy drug (such as sipuleucel-T, pembrolizumab, or nivolumab), the clinic, and the number of treatment cycles needed. In the United States, the average cost is $102,500 (per ASCO). Immunotherapy for prostate cancer in Ukraine is about 87% less than in the U.S.
Ukrainian clinics usually include the initial consultation, diagnostic testing, immunotherapy drug administration, nursing care, and basic follow-up visits in the quoted price. In the U.S., the listed price often covers only the drug itself, with separate bills for consultations, lab tests, and infusion services. Patients should confirm exactly which services and medications are included in each clinic’s package.